GSK

GlaxoSmithKline partners with fast-growing Zymeworks on antibody programs
Fierce Biotech
Thu, 12/3/15 - 09:32 am
GSK
Zymeworks
antibodies
R&D
Thrice-rejected antidepressant, decades in the making, up for FDA review (yet) again
Stat
Tue, 12/1/15 - 01:16 pm
antidepressants
gepirone
Fabre-Kramer
GSK
FDA
advisory panels
One potential reason for GSK's sluggish Breo and Anoro sales
Fierce Pharma Marketing
Mon, 11/30/15 - 06:55 pm
GSK
Breo Ellipta
Anoro Ellipta
GSK's anticorruption overhaul in China may be hobbling sales
Fierce Pharma
Mon, 11/30/15 - 06:46 pm
GSK
China
Valeant, Glaxo, Novartis Skin Drug Prices Have Soared
Investors.com
Fri, 11/27/15 - 12:01 pm
drug pricing
Valeant Pharmaceuticals
GSK
Novartis
dermatology
GlaxoSmithKline inks a back-loaded $100M deal with Idera for renal R&D
Fierce Biotech
Tue, 11/24/15 - 09:45 am
GSK
Idera Pharmaceuticals
renal disease
R&D
GSK Has The Nerve To Innovate Medicine
Forbes
Mon, 11/16/15 - 10:47 am
GSK
innovation
bioelectric medicine
Better Dividend Stock: Pfizer vs. GlaxoSmithKline
Motley Fool
Sat, 11/14/15 - 11:29 am
dividends
Pfizer
GSK
GSK shoots for diabetes-esque platform approach with new respiratory med in hand
Fierce Pharma Marketing
Wed, 11/11/15 - 09:18 pm
GSK
diabetes
severe asthma
Nucala
AstraZeneca, GlaxoSmithKline stake rival claims on new lupus therapies
Fierce Biotech
Wed, 11/11/15 - 09:56 am
AstraZeneca
GSK
lupus
Benlysta
MEDI-546
GSK, Gates Foundation help immuno-oncology player to $56M Series A round
Fierce Biotech
Thu, 11/5/15 - 08:33 pm
GSK
Bill Gates
immuno-oncology
Atreca
HPV vaccine not linked to chronic pain or fainting: European regulators
Pharmalot
Thu, 11/5/15 - 12:50 pm
HPV
vaccines
Europe
Gardasil
Cervarix
GSK
Merck
Glaxo wins US approval for drug to treat severe asthma
Yahoo/AP
Thu, 11/5/15 - 09:45 am
GSK
asthma
Nucala
GSK and Merck to Study Immunotherapy Combination as Potential Cancer Treatment
Yahoo
Tue, 11/3/15 - 02:17 pm
GSK
Merck
GSK3174998
Keytruda
cancer immunotherapy
GSK boss silent on report drugmaker rebuffed Pfizer
Yahoo/Reuters
Tue, 11/3/15 - 10:14 am
GSK
Pfizer
M&A
Glaxo to Submit 20 New Drugs Within Five Years, Repeats Forecast
Bloomberg
Tue, 11/3/15 - 08:53 am
GSK
The top 10 biopharma pipeline disasters of 2015
Fierce Biotech
Fri, 10/30/15 - 09:55 am
Eli Lilly
GSK
AstraZeneca
Shire
Celladon
Takeda
Merck
Roche
Verastem
evacetrapib
Breo Ellipta
brodalumab
selumetinib
SHP625
Mydicar
Alisertib
suggammadex
sembragiline
Defactinib
GSK readies respiratory sales force to challenge Xolair in severe asthma
Fierce Pharma Marketing
Thu, 10/29/15 - 01:20 pm
GSK
Xolair
severe asthma
asthma
Nucala
Novartis
GSK chief: We don't need a breakup or a Pfizer deal. Just look at ViiV's sales surge
Fierce Pharma
Wed, 10/28/15 - 03:14 pm
GSK
Pfizer
M&A
ViiV Healthcare
Andrew Witty
Glaxo faces another cardio R&D failure for a lead candidate
BioPharma Dive
Wed, 10/28/15 - 02:55 pm
GSK
R&D
losmapimod

Pages